We are live on ! Find out more
DNTH icon

Dianthus Therapeutics

97 hedge funds and large institutions have $366M invested in Dianthus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

77% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 22

8% more funds holding

Funds holding: 9097 (+7)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.55% less ownership

Funds ownership: 4.55%4% (-0.55%)

12% less capital invested

Capital invested by funds: $418M → $366M (-$52.1M)

Holders
97
Holders Change
+7
Holders Change %
+7.78%
% of All Funds
1.69%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
39
Reduced
22
Closed
9
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$556K
Name Holding Trade Value Shares
Change
Change in
Stake
ECM
101
ExodusPoint Capital Management
New York
-$229K -1,210 Closed
Ensign Peak Advisors
102
Ensign Peak Advisors
Utah
-$37K -198 Closed
HPC
103
HM Payson & Co
Maine
-$17K -89 Closed
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
-$8K -38 Closed
EI
105
Ellevest Inc
New York
+$367 +2 +200%